Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
3.960
-0.650 (-14.10%)
At close: Feb 20, 2026, 4:00 PM EST
4.060
+0.100 (2.53%)
After-hours: Feb 20, 2026, 7:44 PM EST

Ironwood Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
6447091,7861,9011,9081,824
Market Cap Growth
90.76%-60.31%-6.02%-0.40%4.64%-12.64%
Enterprise Value
1,1021,2362,4141,7421,8041,964
Last Close Price
3.964.4311.4412.3911.6611.39
PE Ratio
22.36805.60-10.863.6117.17
Forward PE
5.2813.4214.1411.248.4310.89
PS Ratio
1.902.024.034.634.614.68
PB Ratio
--2.35-5.162.913.1529.11
P/TBV Ratio
---2.913.1529.11
P/FCF Ratio
9.526.869.756.957.2910.92
P/OCF Ratio
9.526.859.746.947.2910.80
PEG Ratio
--1.982.251.210.71
EV/Sales Ratio
3.253.525.454.244.365.04
EV/EBITDA Ratio
7.5712.6412.236.927.7212.23
EV/EBIT Ratio
7.6712.9112.336.967.7712.41
EV/FCF Ratio
16.2911.9513.186.376.9011.76
Debt / Equity Ratio
-2.26-1.99-2.070.640.797.24
Debt / EBITDA Ratio
4.025.893.561.632.012.76
Debt / FCF Ratio
8.845.803.911.521.822.72
Net Debt / Equity Ratio
-1.73-1.70-1.80-0.37-0.241.46
Net Debt / EBITDA Ratio
3.145.233.16-0.95-0.620.57
Net Debt / FCF Ratio
6.774.943.40-0.88-0.550.55
Asset Turnover
0.860.860.560.370.490.81
Quick Ratio
1.084.390.8030.234.5415.07
Current Ratio
1.134.700.8530.584.6115.41
Return on Equity (ROE)
---674.04%27.83%158.09%-
Return on Assets (ROA)
22.88%14.56%15.58%14.05%17.21%20.57%
Return on Invested Capital (ROIC)
22.42%0.53%56.83%39.75%75.47%98.13%
Return on Capital Employed (ROCE)
93.60%30.70%100.40%23.30%24.10%30.00%
Earnings Yield
4.43%0.12%-56.11%9.21%27.69%5.82%
FCF Yield
10.50%14.59%10.25%14.40%13.71%9.16%
Buyback Yield / Dilution
-9.90%-2.99%16.57%-13.32%-2.34%-2.97%
Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q